Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 5
1975 4
1976 1
1977 1
1978 3
1979 1
1980 2
1981 3
1982 3
1983 2
1984 11
1985 8
1986 8
1987 9
1988 7
1989 13
1990 11
1991 10
1992 12
1993 8
1994 4
1995 8
1996 12
1997 9
1998 13
1999 7
2000 11
2001 12
2002 17
2003 13
2004 13
2005 21
2006 20
2007 15
2008 9
2009 6
2010 9
2011 5
2012 6
2013 4
2014 3
2015 8
2016 3
2017 5
2018 2
2019 1
2020 2
2021 2
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

355 results
Results by year
Filters applied: . Clear all
Page 1
Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration.
Mandai M, Watanabe A, Kurimoto Y, Hirami Y, Morinaga C, Daimon T, Fujihara M, Akimaru H, Sakai N, Shibata Y, Terada M, Nomiya Y, Tanishima S, Nakamura M, Kamao H, Sugita S, Onishi A, Ito T, Fujita K, Kawamata S, Go MJ, Shinohara C, Hata KI, Sawada M, Yamamoto M, Ohta S, Ohara Y, Yoshida K, Kuwahara J, Kitano Y, Amano N, Umekage M, Kitaoka F, Tanaka A, Okada C, Takasu N, Ogawa S, Yamanaka S, Takahashi M. Mandai M, et al. Among authors: takasu n. N Engl J Med. 2017 Mar 16;376(11):1038-1046. doi: 10.1056/NEJMoa1608368. N Engl J Med. 2017. PMID: 28296613 Free article.
Non-clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell-derived anti-glypican-3 chimeric antigen receptor-expressing natural killer/innate lymphoid cells.
Ueda T, Kumagai A, Iriguchi S, Yasui Y, Miyasaka T, Nakagoshi K, Nakane K, Saito K, Takahashi M, Sasaki A, Yoshida S, Takasu N, Seno H, Uemura Y, Tamada K, Nakatsura T, Kaneko S. Ueda T, et al. Among authors: takasu n. Cancer Sci. 2020 May;111(5):1478-1490. doi: 10.1111/cas.14374. Epub 2020 Mar 31. Cancer Sci. 2020. PMID: 32133731 Free PMC article.
Retraction. Resistance to Apo2 ligand (Apo2L)/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis and constitutive expression of Apo2L/TRAIL in human T-cell leukemia virus type 1-infected T-cell lines. Journal of Virology, Volume 79, no. 3, p. 1367-78, 2005.
Matsuda T, Almasan A, Tomita M, Uchihara JN, Masuda M, Ohshiro K, Takasu N, Yagita H, Ohta T, Mori N. Matsuda T, et al. Among authors: takasu n. J Virol. 2011 Feb;85(3):1416. doi: 10.1128/JVI.02070-10. J Virol. 2011. PMID: 21228250 Free PMC article. No abstract available.
Overview: an iPS cell stock at CiRA.
Umekage M, Sato Y, Takasu N. Umekage M, et al. Among authors: takasu n. Inflamm Regen. 2019 Sep 2;39:17. doi: 10.1186/s41232-019-0106-0. eCollection 2019. Inflamm Regen. 2019. PMID: 31497180 Free PMC article. Review.
CiRA iPSC seed stocks (CiRA's iPSC Stock Project).
Hanatani T, Takasu N. Hanatani T, et al. Among authors: takasu n. Stem Cell Res. 2020 Oct 9;50:102033. doi: 10.1016/j.scr.2020.102033. Online ahead of print. Stem Cell Res. 2020. PMID: 33445065 Free article.
Rifampin-induced hypothyroidism.
Takasu N, Kinjou Y, Kouki T, Takara M, Ohshiro Y, Komiya I. Takasu N, et al. J Endocrinol Invest. 2006 Jul-Aug;29(7):645-9. doi: 10.1007/BF03344165. J Endocrinol Invest. 2006. PMID: 16957414
355 results